Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 156.25 | 36.27 | 96.00 | 126.50 | 0.7589 | 0.7161 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 187.00 | 126.50 | 1.4783 | 1.4844 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 156.25 | 36.27 | 127.00 | 126.50 | 1.0040 | 1.0044 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 36.27 | 163.00 | 126.50 | 1.2885 | 1.3021 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 187.00 | 126.50 | 1.4783 | 1.4844 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 156.25 | 36.27 | 185.00 | 126.50 | 1.4625 | 1.4696 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 179.00 | 126.50 | 1.4150 | 1.4248 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 120.00 | 126.50 | 0.9486 | 0.9423 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 36.27 | 197.00 | 126.50 | 1.5573 | 1.5572 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 134.00 | 126.50 | 1.0593 | 1.0649 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 36.27 | 142.00 | 126.50 | 1.1225 | 1.1325 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 156.25 | 36.27 | 72.00 | 126.50 | 0.5692 | 0.4629 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 156.25 | 36.27 | 78.00 | 126.50 | 0.6166 | 0.5294 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 156.25 | 36.27 | 77.00 | 126.50 | 0.6087 | 0.5185 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 135.00 | 126.50 | 1.0672 | 1.0735 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 126.00 | 126.50 | 0.9961 | 0.9956 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 36.27 | 105.00 | 126.50 | 0.8300 | 0.8036 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 98.00 | 126.50 | 0.7747 | 0.7359 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 67.00 | 126.50 | 0.5296 | 0.4057 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 113.00 | 126.50 | 0.8933 | 0.8786 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 146.00 | 126.50 | 1.1542 | 1.1656 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 156.25 | 36.27 | 95.00 | 126.50 | 0.7510 | 0.7062 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 103.00 | 126.50 | 0.8142 | 0.7845 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 36.27 | 93.00 | 126.50 | 0.7352 | 0.6862 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 128.00 | 126.50 | 1.0119 | 1.0131 |